Search results for "Prostate cancer"
Task Force draft recommendation leaves PSA screening choice up to patients
Clinicians should talk to men ages 55 to 69 about the potential benefits and harms of screening, according to the U.S. Preventive Services Task Force. For men ages 70 years and older, the potential benefits of prostate-specific antigen (PSA)-based screening do not outweigh the harms, the Task Force said.
https://immattersacp.org/weekly/archives/2017/04/18/1.htm
18 Apr 2017
Dealing with dementia, Q&As on COVID-19
This issue also covers testosterone and men's health, as well as preconception care.
https://immattersacp.org/archives/2020/05/dealing-with-dementia-qandas-on-covid-19.htm
1 May 2020
PSA screening halves cancer mortality
Cancer diagnoses often given quickly, impersonallyEmail improved care for diabetics
https://immattersacp.org/weekly/archives/2010/07/13/4.htm
13 Jul 2010
Taking a drink: what patients should know
Alcohol is associated with so many benefits and harms that it's hard to know where to start talking to patients about using it. One place might be alcohol misuse and abuse. Teach patients where they fall on the continuum of drinking behavior.
https://immattersacp.org/archives/2013/01/alcohol.htm
1 Jan 2013
CONFERENCE COVERAGE Information plus documentation a must for informed ...
In 1990, Dr. Gottesman was sued forlate diagnosis of a patient’s prostate cancer.He won the case, and one of the jurors toldhim that the deciding factor had beeninformed consent ... documentation showingthat the patient had been warned that abiopsy could miss cancer.
https://immattersacp.org/archives/2012/01/acpi-201201-coding_t4.pdf
19 Dec 2011
Tailor prostate screening based on life expectancy, ASCO recommends
A provisional clinical opinion from the American Society of Clinical Oncology (ASCO) recommends against prostate-specific antigen screening for men with a life expectancy of 10 years or less.
https://immattersacp.org/weekly/archives/2012/07/24/2.htm
24 Jul 2012
Recall of generic drugs, acne cream; depression device OK'd
A summary of approvals, recalls and a record number of deaths and serious injuries reported.
https://immattersacp.org/archives/2009/01/recall.htm
1 Jan 2009
Research model supports strategies that increase PSA screening interval and age-specific thresholds for biopsy
Using higher thresholds for biopsy referral for older men and screening men with initially low prostate-specific antigen (PSA) levels less frequently seem to reduce harms of screening while preserving lives, a study found.
https://immattersacp.org/weekly/archives/2013/02/05/5.htm
5 Feb 2013
Warfarin recalled, type 2 diabetes drug approved
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/07/fda.htm
1 Jul 2011
Communication skills vital to cancer conversations
Cancer patients want information, but not in a way that makes them lose hope. Effective shared decision making and risk communication strategies can help.
https://immattersacp.org/archives/2013/09/communication.htm
1 Sep 2013